- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01221194
Therapeutic Stockings to Prevent Foot Ulcers
August 12, 2020 updated by: Larry Lavery, University of Texas Southwestern Medical Center
- To evaluate the efficacy of a therapeutic stockings (Protective Foot Care stockings, PFC) in reducing the incidence of diabetic foot pathology among high-risk patients.
- To evaluate perceived health-related quality of life as compared to guideline directed usual care in patients who use the PFC stockings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We will identify a cohort of high-risk diabetic patients and assign them to two treatment groups.
We plan to enroll patients from three sites: Scott and White Hospital in Temple Texas, Manchester Royal Infirmary, UK , and Trinity College Dublin at St James Hospital..
The two treatment arms will involve a Standard Therapy Group, and a Stocking Therapy Group.
The Stocking Therapy group will use the special padded and friction reducing stockings in their standard shoes during the course of the study.
Patient enrollment will occur over a one-year period.
All patients will be followed for 30 months.
The Standard Therapy Group will receive therapeutic shoes, standard insoles, patient education and regular foot evaluations by a physician every 10-12 weeks.
The Stocking Therapy Group will receive standard therapy as described above but use the special stockings instead of their usual hose.
The investigator at each site will be blinded regarding the treatment.
Study Type
Interventional
Enrollment (Actual)
381
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom
- University of Manchester
-
-
-
-
Texas
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center at Dallas
-
Dallas, Texas, United States, 75235
- Parkland Health & Hospital Systems
-
Temple, Texas, United States, 76502
- Scott & White
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men or women 18 years old or older
- Diagnosis of Diabetes Mellitus*
- History of diabetes related foot ulceration
Spanish-speaking subjects will be eligible to participate.
Exclusion Criteria:
- Active Charcot Arthropathy
- Gangrene, active infection
- Midfoot or higher level amputation
- Alcohol or substance abuse within 6 months
- Unreliable, unwilling or unable to comprehend informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Standard therapy
Standard therapy consisting of education, regular foot care and protective shoes and insoles.
The standard therapy group will use the stockings they normally wear.
|
Standard therapy consisting of education, regular foot care and protective shoes and insoles.
The standard therapy group will use the stockings they normally wear.
|
ACTIVE_COMPARATOR: PFC Stockings
The stocking therapy group will be given PFC shear reducing stockings to wear.
|
A pressure and friction reducing stocking.
The novelty of the PFC Sock stems from its innovative double layer structure and technological fibre composition.
These simultaneously and significantly reduce both pressure and friction in a format that is practical for everyday wear with therapeutic shoes in high-risk cases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Who Developed Foot Ulcer During Study Time Frame
Time Frame: 30 months
|
An ulceration will be defined as full thickness loss of epidermis and dermis or involvement of deeper structures.
|
30 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (ACTUAL)
February 1, 2016
Study Completion (ACTUAL)
March 1, 2016
Study Registration Dates
First Submitted
October 13, 2010
First Submitted That Met QC Criteria
October 13, 2010
First Posted (ESTIMATE)
October 14, 2010
Study Record Updates
Last Update Posted (ACTUAL)
August 26, 2020
Last Update Submitted That Met QC Criteria
August 12, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 082010-090
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on Standard therapy
-
Castilla-La Mancha Health ServiceComplejo Hospitalario La Mancha CentroCompletedSubacromial Impingement Syndrome | Vojta TherapySpain
-
Institute of Cardiology, Warsaw, PolandUnknownCardiac RehabilitationPoland
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Swiss Group for Clinical Cancer ResearchTerminatedMetastatic Colorectal CancerSwitzerland, Austria
-
University of Alabama at BirminghamWithdrawn
-
CardioRenal Systems, Inc.Active, not recruitingContrast Induced NephropathyUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...RecruitingLymphoma | Multiple MyelomaUnited States
-
Brooke Army Medical CenterUniformed Services University of the Health Sciences; The Geneva FoundationRecruitingMetatarsal Stress Fracture | Stress Fracture of TibiaUnited States
-
Dana-Farber Cancer InstituteRecruitingCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States